KADIAN 20 mg (Morphine Sulfate Extended-Release 20 mg)

Pill with imprint KADIAN 20 mg is Yellow, Capsule-shape and has been identified as Morphine Sulfate Extended-Release 20 mg. It is supplied by Actavis.

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 20 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for KADIAN 20 mg

Morphine sulfate extended-release 20 mg KADIAN 20 mg

Morphine Sulfate Extended-Release

Imprint: KADIAN 20 mg
Strength: 20 mg
Color: Yellow
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Narcotic analgesics
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: 2 - High potential for abuse
Labeler / Supplier: Actavis
Inactive Ingredients: hypromelloses, ethylcellulose, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol, diethyl phthalate, magnesium silicate, corn starch, sucrose, gelatin, silicon dioxide, sodium lauryl sulfate, titanium dioxide, D&C Yellow No. 10, shellac, ferrosoferric oxide, potassium hydroxide, propylene glycol
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00228-3502	Actavis Pharma, Inc.
49884-0833 (Discontinued)	Par Pharmaceutical, Inc.
52544-0211 (Discontinued)	Watson Pharmaceuticals, Inc.
54868-4571 (Discontinued)	Physicians Total Care Inc. (repackager)
35356-0048 (Discontinued)	Lake Erie Medical and Surgical Supply (repackager)